EUR-Lex Access to European Union law
This document is an excerpt from the EUR-Lex website
Document C:2004:172:FULL
Official Journal of the European Union, C 172, 02 July 2004
Official Journal of the European Union, C 172, 02 July 2004
Official Journal of the European Union, C 172, 02 July 2004
ISSN 1725-2423 |
||
Official Journal of the European Union |
C 172 |
|
English edition |
Information and Notices |
Volume 47 |
Notice No |
Contents |
page |
|
I Information |
|
|
Commission |
|
2004/C 172/1 |
||
2004/C 172/2 |
||
2004/C 172/3 |
||
EN |
|
I Information
Commission
2.7.2004 |
EN |
Official Journal of the European Union |
C 172/1 |
Euro exchange rates (1)
1 July 2004
(2004/C 172/01)
1 euro=
|
Currency |
Exchange rate |
USD |
US dollar |
1,2168 |
JPY |
Japanese yen |
131,64 |
DKK |
Danish krone |
7,4335 |
GBP |
Pound sterling |
0,6701 |
SEK |
Swedish krona |
9,1615 |
CHF |
Swiss franc |
1,5232 |
ISK |
Iceland króna |
88,43 |
NOK |
Norwegian krone |
8,441 |
BGN |
Bulgarian lev |
1,9558 |
CYP |
Cyprus pound |
0,5815 |
CZK |
Czech koruna |
31,875 |
EEK |
Estonian kroon |
15,6466 |
HUF |
Hungarian forint |
251,35 |
LTL |
Lithuanian litas |
3,4529 |
LVL |
Latvian lats |
0,6563 |
MTL |
Maltese lira |
0,4262 |
PLN |
Polish zloty |
4,5005 |
ROL |
Romanian leu |
40 629 |
SIT |
Slovenian tolar |
239,85 |
SKK |
Slovak koruna |
39,845 |
TRL |
Turkish lira |
1 791 400 |
AUD |
Australian dollar |
1,7283 |
CAD |
Canadian dollar |
1,6172 |
HKD |
Hong Kong dollar |
9,4907 |
NZD |
New Zealand dollar |
1,9013 |
SGD |
Singapore dollar |
2,0875 |
KRW |
South Korean won |
1 402,54 |
ZAR |
South African rand |
7,5203 |
Source: reference exchange rate published by the ECB.
2.7.2004 |
EN |
Official Journal of the European Union |
C 172/2 |
NOTICE OF INITIATION
of a partial interim review of the anti-dumping measures applicable to imports of ammonium nitrate originating in Russia and Ukraine
(2004/C 172/02)
The Commission has received a request for a partial interim review pursuant to Article 11(3) of Council Regulation (EC) No 384/96 (1) (‘the basic Regulation’).
1. Request for review
The request was lodged by the European Fertilizer Manufacturers Association (‘the applicant’).
2. Product
The product under review is ammonium nitrate other than in aqueous solution and mixtures of ammonium nitrate with calcium carbonate or other inorganic non-fertilising substances, with a nitrogen content exceeding 28 % by weight, originating in Russia and Ukraine ('the product concerned'), normally classifiable within CN codes 3102 30 90 and 3102 40 90. These CN codes are given only for information.
3. Existing measures
The measures currently in force are a definitive anti-dumping duty imposed by Council Regulation (EC) 132/2001 (2) on imports of ammonium nitrate originating, inter alia, in Ukraine and by Council Regulation (EC) No 658/2002 (3) on imports of ammonium nitrate originating in Russia.
4. Grounds for the review
The applicant has provided information that the scope of the existing measure is no longer sufficient to counteract the dumping which is causing injury.
The applicant alleges that new product types have appeared on the market which should be included in the scope of the measures on the grounds that they share the same basic physical and chemical characteristics and end uses as the product covered by the measures. Both the product concerned and the new product types should therefore be considered as a single product.
5. Procedure for the determination of dumping
Having determined, after consulting the Advisory Committee, that sufficient evidence exists to justify the initiation of a partial interim review, the Commission hereby initiates a review in accordance with Article 11(3) of the basic Regulation, limited in scope to the definition of the product concerned.
The investigation will assess the need for the amendment of the scope of the existing measure.
(a) Questionnaires
In order to obtain the information it deems necessary for its investigation, the Commission will send questionnaires to the applicant, to the importers, to the users, to exporting producers in Russia and Ukraine, to the exporters and to the Russian and Ukrainian authorities. This information and supporting evidence should reach the Commission within the time limit set in point 6(a) of this notice.
(b) Collection of information and holding of hearings
All interested parties are hereby invited to make their views known, submit information other than questionnaire replies and to provide supporting evidence. This information and supporting evidence must reach the Commission within the time limit set in paragraph 6(a) of this notice.
Furthermore, the Commission may hear interested parties, provided that they make a request showing that there are particular reasons why they should be heard. This request must be made within the time limit set in paragraph 6(b) of this notice.
6. Time limits
(a) For parties to make themselves known, to submit questionnaire replies and any other information
All interested parties, if their representations are to be taken into account during the investigation, must make themselves known by contacting the Commission, present their views and submit questionnaire replies or any other information within 40 days of the date of publication of this notice in the Official Journal of the European Union, unless otherwise specified. Attention is drawn to the fact that the exercise of most procedural rights set out in the basic Regulation depends on the party's making itself known within the aforementioned period.
(b) Hearings
All interested parties may also apply to be heard by the Commission within the same 40-day time limit.
7. Written submissions, questionnaire replies and correspondence
All submissions and requests made by interested parties must be made in writing (not in electronic format, unless otherwise specified and must indicate the name, address, e-mail address, telephone and fax, and/or telex numbers of the interested party). All written submissions, including the information requested in this notice, questionnaire replies and correspondence provided by interested parties on a confidential basis shall be labelled as ‘Limited’ (4) and, in accordance with Article 19(2) of the basic Regulation, shall be accompanied by a non-confidential version, which will be labelled ‘for inspection by interested parties’.
Commission address for correspondence:
European Commission |
Directorate General for Trade |
Directorate B |
Office: J-79 5/16 |
B-1049 Brussels |
Fax (32 2) 295 65 05 |
Telex COMEU B 21877. |
8. Non-co-operation
In cases in which any interested party refuses access to or otherwise does not provide the necessary information within the time limits, or significantly impedes the investigation, findings, affirmative or negative, may be made in accordance with Article 18 of the basic Regulation, on the basis of the facts available.
Where it is found that any interested party has supplied false or misleading information, the information shall be disregarded and use may be made, in accordance with Article 18 of the basic Regulation, of the facts available. If an interested party does not co-operate, or co-operates only partially, and use of the best facts available is made, the result may be less favourable to the party than if it had co-operated.
(1) OJ L 56, 6.3.1996, p. 1. Regulation as last amended by Regulation (EC) No 461/2004 (OJ L 77, 13.3.2004, p. 12).
(3) OJ L 102, 18.4.2002, p. 1.
(4) This means that the document is for internal use only. It is protected pursuant to Article 4 of Regulation (EC) No 1049/2001 of the European Parliament and of the Council (OJ L 145, 31.5.2001, p. 43). It is a confidential document pursuant to Article 19 of Council Regulation (EC) No 384/96 (OJ L 56, 6.3.1996, p. 1) and Article 6 of the WTO Agreement on Implementation of Article VI of the Gatt 1994 (Anti-dumping Agreement).
2.7.2004 |
EN |
Official Journal of the European Union |
C 172/4 |
Summary of Community decisions on marketing authorization in respect of medicinal products from 15/04/2004 to 15/05/2004
(Published pursuant to Article 12 or Article 34 of Council Regulation (EEC) No 2309/93 (1))
(2004/C 172/03)
Issuing of a marketing authorization (Article 12 of Council Regulation (EEC) No 2309/93) Accepted
Date of the decision |
Name of the medicinal product |
Holder of the marketing authorization |
Number of the entry in the Community Register |
Date of notification |
||||||
26.04.2004 |
Velcade |
|
EU/1/04/274/001 |
28.04.2004 |
||||||
28.04.2004 |
Lysodren |
|
EU/1/04/273/001 |
30.04.2004 |
||||||
28.04.2004 |
Dukoral |
|
EU/1/03/263/001-003 |
03.05.2004 |
Modification of a marketing authorization (Article 12 of Council Regulation (EEC) No 2309/93) Accepted
Date of the decision |
Name of the medicinal product |
Holder of the marketing authorization |
Number of the entry in the Community Register |
Date of notification |
||||||
22.04.2004 |
Onsenal |
|
EU/1/03/259/001-006 |
04.05.2004 |
||||||
22.04.2004 |
Kudeq |
|
EU/1/02/244/001-024 |
27.04.2004 |
||||||
22.04.2004 |
Bextra |
|
EU/1/02/239/001-024 |
04.05.2004 |
||||||
22.04.2004 |
Dynastat |
|
EU/1/02/209/001-008 |
04.05.2004 |
||||||
22.04.2004 |
Rayzon |
|
EU/1/02/210/001-008 |
04.05.2004 |
||||||
28.04.2004 |
Zerit |
|
EU/1/96/009/001-017 |
30.04.2004 |
||||||
28.04.2004 |
Viracept |
|
EU/1/97/054/006 |
30.04.2004 |
||||||
29.04.2004 |
Stocrin |
|
EU/1/99/111/001-009 |
07.05.2004 |
||||||
29.04.2004 |
Sustiva |
|
EU/1/99/110/001-009 |
04.05.2004 |
||||||
07.05.2004 |
Ferriprox |
|
EU/1/99/108/001 |
11.05.2004 |
||||||
10.05.2004 |
Enbrel |
|
EU/1/99/126/001-003 |
12.05.2004 |
||||||
11.05.2004 |
Cancidas |
|
EU/1/01/196/001-003 |
13.05.2004 |
||||||
13.05.2004 |
Cancidas |
|
EU/1/01/196/001-003 |
17.05.2004 |
Issuing of a marketing authorization (Article 34 of Council Regulation (EEC) No 2309/93) Accepted
Date of the decision |
Name of the medicinal product |
Holder of the marketing authorization |
Number of the entry in the Community Register |
Date of notification |
||||
07.05.2004 |
Equilis StrepE |
|
EU/2/04/043/001 |
11.05.2004 |
Modification of a marketing authorization (Article 34 of Council Regulation (EEC) No 2309/93) Accepted
Date of the decision |
Name of the medicinal product |
Holder of the marketing authorization |
Number of the entry in the Community Register |
Date of notification |
||||
28.04.2004 |
SevoFlo |
|
EU/2/02/035/001-006 |
30.04.2004 |
||||
28.04.2004 |
Locatim |
|
EU/2/99/011/001 |
29.04.2004 |
Anyone wishing to consult the public assessment report on the medicinal products in question and the decisions relating thereto is invited to contact:
The European Agency for the Evaluation of Medicinal products |
7, Westferry Circus, Canary Wharf |
LONDON E14 4HB |
United Kingdom |
(1) OJ L 214 du 24 August 1993, page 1.